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ABSTRACT OF THE THESIS
HEART VALVE TISSUE ENGINEERING: A STUDY OF TIME VARYING EFFECTS
AND SAMPLE GEOMETRY
by
Manuel Salinas
Florida International University, 2011
Miami, Florida
Professor Sharan Ramaswamy, Major Professor
In heart valve tissue engineering (HVTE), it is well established that mechanical
stimuli improve tissue formation and cell growth. Previous experiments have shown that
combined flexure and flow increases tissue formation in PLA/PGA scaffolds seeded with
bone marrow derived stem cells (BMSCs). In addition, computational fluid dynamic
(CFD) studies have shown that sample bending significantly affects the flow physics. The
intend of this study was to observe and compare the flow physics between steady state
and pulsatile cases through computational modeling and in-vitro experiments. A u-shaped
custom made bioreactor capable of producing flow stretch and flexure was used. CFD
simulations were performed through Ansys CFX (Ansys, Pittsburgh, PA) for both steady
and pulsatile flow. The results have shown that OSS can be maximized by inducing
pulsatile flow over straight scaffolds. Evidence suggests that OSS promotes BMSCs
tissue formation.
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1 INTRODUCTION
Heart valve disease is a major health care concern around the world. It is
estimated that over 290,000 replacements occur annually, and it is expected to triple in
the next four decades [1]. Native heart valves (NHVs) are multilayered highly adaptable
and highly regulated structures. NHVs open and close nearly three billion times in an
average lifespan and their motion depend on the mechanical and hemodynamic forces
[2]. Healthy pulmonary heart valves (PHVs) assure one-way blood flow from the right
ventricle into the pulmonary artery with minimum regurgitation and negligible
obstruction during systole. During diastole, the PHV closes when the pulmonary artery
pressure exceeds the ventricular pressure. The closing of the PHVs is aided by flow
vortices behind the cusps on the arterial side [2]. Native PHVs are subjected to complex
time-varying stresses due to combinations of flow, stretch and flexure (FSF). They are
tightly regulated with continuous tissue remodeling activity capable of adapting to
different hemodynamic loads [3].
Prosthetic heart valves have shown to provide sufficient functionality; however,
mechanical heart valves (MHVs) are prone to hemolysis and possible platelet activation
due to abnormal hemodynamics [4]. On the other hand, biological heart valves (BHVs)
can fail due to calcification and immune rejection [3,5]. MHVs are widely used among
pediatric patients due to the risk of BHV calcification resulting from elevated calcium
concentration found in children [6]. However with MHVs, several revision surgeries are
necessary to account for the growth of the child. In addition, immune rejection is still a
problem. Ultimately, prosthetic heart valves do not address tissue adaptation, which is
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sorely needed among pediatric patients suffering from severe congenital valve
disease/abnormalities.
The objectives of this proposal are to study the effects of two parameters that
could potentially augment in vitro engineered heart valve tissue formation. These
parameters are linked to the general process of mechanical conditioning which is thought
to be important in optimizing tissue formation [7,8]. Specifically, this work examined the
effects of i) sample geometry and ii) pulsatility on fluid-induced stress states and
subsequent implications that may have on engineered tissue formation, which are
addressed in the following specific aims.
2 SPECIFIC AIMS
Aim 1: Understand the role of specimen geometry in the context of heart valve
tissue engineering studies.
Changes in specimen geometry results in spatially varying flow physics. The
intention is to observe the flow physics that occurs during sample flexure. In order to
do this, computational fluid dynamics (CFD) simulations were performed as described
in the methods section.
Aim 2: Understand the role of pulsatility in the context of heart valve tissue
engineering studies.
Pulsatility introduces frequency, waveform, and oscillatory effects. These time
varying effects that may be important in the development of tissue engineered heart
valve (TEHV) constructs.
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Aim 3: Co-relate the role of steady and pulsatile flow-induced stress states to
engineered tissue formation, specifically collagen and glycosaminoglycan (GAGs)
production by bone marrow derived stem cells (BMSCs).
Spatial and time varying stress effects may improve tissue formation in TEHV
constructs seeded with BMSCs. Recent studies in heart valve tissue engineering have
used BMSCs because they are less invasive than other cell sources such as endothelial
cells (ECs) or smooth muscle cells (SMCs). Comparison of these simulations
with experimental data was performed.
3 LITERATURE REVIEW
3.1 Heart Valve Disease
Heart Valve disease (HVD) is any of the conditions in which the functioning of
one or more of the native heart valves (NHVs) is affected. HVD can be caused by
immune reactions, trauma, genetic and congenital factors as well as environmental
factors such as diet, smoking habits, and sedentary life. It could affect any of the four
valves such as the pulmonary ones [9-13]. There are four valves in the heart and they
open and close in a synchronized manner permitting the blood to travel unidirectionally.
The atrio-ventricular (A-V) valves (mitral and tricuspid) open when the pressure in the
atrium exceeds the pressure in the ventricles and allows blood to flow inside the latter. In
the same manner, when the pressure in the ventricles exceeds that of the atrium in the AV valves close. Subsequently, as ventricles contract, the pulmonary and aortic valves
open allowing blood to flow towards the lungs and aortic artery respectively.
Valve stenosis occurs when the valves become stiff or fuse together. This
decreases the cross sectional area for blood to flow normally thereby affecting the
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hemodynamics. Another form of HVD is valve regurgitation. In this case, valves do not
close properly and cause blood to flow back to the heart. As a consequence, blood flow to
the body can be significantly diminished, therefore making the heart work harder [14,15].
Pulmonary valves are responsible for allowing blood flow from the heart to the
lungs for carbon dioxide and oxygen exchange. When the valve has undergone sufficient
damage, it needs to be replaced by commercially available prosthetic heart valves. There
are approximately 15000 pulmonary heart valve replacements each year [16]. In 1995, it
was shown that it is possible to substitute single native pulmonary leaflets with tissue
engineered leaflet constructs [17] in lambs. Other studies have reported using trileaflet
constructs for grafting in sheep and it showed to last for up to 8 months before implant
failure [17].
3.2 Heart Valve prosthetics
Prosthetic heart valves can be classified as either mechanical or bio-prosthetic.
Mechanical heart valves (MHVs) are typically constructed out of a high strength material
such as titanium or pyrolytic carbon. MHVs initial designs include the ball and cage,
tilting disk, and the bileaflet versions. One of the bileaflet designs the St. Jude Medical
MHV, is the most widely used type of mechanical implant because of superior
hemodynamics over the other two designs due to lower transvalvular pressure drop
[6,18,19]. MHVs offer durability and reliability, but they have problems such as
hemolysis and possible platelet activation due to abnormal hemodynamics [13,20,21].
MHVs are recommended for use in adults, but they are contraindicated for children
because they do not account for somatic growth [14,22].
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Bio-prosthetic valves (BPVs) are made of native valves explanted from animals
or cadavers that have undergone proper standards of handling and processing in order to
be used as human implants [15,23]. For xenografts, swines are the number one choice,
but it can also be explanted from bovines [13,15]. Some of the problems that accompany
xenografts or homograft valve implants are calcification and immune rejection which will
lead to implant failure [24-27].

Figure 1. Mechanical and Biological Heart valves.
Heart valve tissue engineering aims at the development of an in-vitro implant with
similar mechanical properties and anatomy as native valves. Moreover, a primary goal of
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this approach is to promote engineered tissue remodeling and growth [8]. However, no
long term/ perpetual reliable engineered valve has been obtained thus far due to the
complexity in mimicking the environments that native valves are exposed to [1,28,29].

Sheep

Autologous cells (i.e. BMSCs)

Conditioned implant

Cell expansion

Cell seeding

Mechanical conditioning

Figure 2. Tissue Engineering Approach
3.3 Computational Fluid Dynamic in Heart Valves
Through computational fluid dynamic (CFD) simulations, it has been shown that
the flow physics acting on native heart valves can be replicated in rectangular
scaffolds[7] Ramaswamy et al.[8] designed a custom made bioreactor able to induce
flow, flexure and stress. The device was capable of housing up to twelve sample
specimens. The design consisted of four u-tube shape pipe-like chambers of 13 mm
diameters. Each chamber is capable of housing up to three samples. It was shown that the
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device was able to reproduce physiologically valid shear stress (5-6 dynes/cm2) [8] while
keeping laminar flow and low viscosity (1.27 centipoise).

Figure 3. Computational fluid dynamic simulations on native heart valve (a)
and rectangular (b) Geometries [7].
3.4 Cell sources for HVTE
Heart valve tissue engineering studies have been conducted using a variety of cell
sources [30-33]. Some studies have focused on endothelial (ECs) and smooth muscle
cells (SMCs). ECs and SMCs can be obtained primarily from vessels such as arteries.
However, this is considered to be an invasive form of obtaining cells because vascular
tissue is compromised and destroyed when extracting these two types of cells [31,34].
Nonetheless, these two cell sources have shown to promote tissue formation in studies
pertaining to engineered heart valves. Human periodontal ligament derived stem cells
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(PDLSCs) [35] are another HVTE cell source. These cells are obtained mainly from
wisdom teeth surgically extracted and can potentially adopt heart valve phenotypes. More
recently, HVTE studies have used bone marrow derived mesenchymal stem cells
(BMSCs) [32,33,36,37].

BMSCs are a practical source autologous progenitor cells

because they can be obtained in large numbers in a minimally invasive manner [7,38].
3.5 Scaffolds
A fundamental aspect in tissue engineering is the use of scaffolds that mimic the
mechanical and homeostatic conditions of NHVs. It is of utmost importance for cell and
tissue development to have a suitable porous interface where colonizing cells can attach,
replicate and produce ECM. Ideally, scaffold degradation rates should match the rate of
mechanically resilient tissue formation [39]. HVTE studies have used polymeric and
biological scaffolds. Polylactic acids (PLA), polyglycolic acid (PGA) have been used as
artificial scaffold materials because of their biocompatibility and biodegradability
[33,40,41]. These scaffolds can be easily constructed and therefore they can be obtained
in an efficient manner [40]. However, the disadvantage is that these scaffolds do not
match the mechanical properties of NHVs and simultaneously offer anatomically shape
retention [33,40,41].
Researchers have also investigated the use of decellularized biological scaffolds
obtained from animal native valves [42]. One of the advantages of using these xenoconstructs is the conservation of the native heart valve architecture and ECM mechanical
properties [1,43]. On the other hand, there are still unsolved compatibility issues. This is
due primarily to the multi-factor interaction between cell sources such as BMSCs and
decellularized extracellular tissue components such as collagen and other proteins [1,3].
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3.6 Mechanical Conditioning
It is well documented that mechanical conditioning plays a role in the in-vitro
development of vascular tissue [7,44,45]. Basic bioreactors provided dynamic
conditioning in the form of fluid flow. These devices include compliance and ventricular
chambers, pneumatic or peristaltic pumps, and sensors. They also use computers with
specialized software for its monitoring. In some of these devices, pressure wave forms,
velocities, and shear stress can be adjusted.
Sodian et al.[16] used a pulsatile bioreactor capable of inducing pulsatile flow and
pressure. It was used to house tri-leaflet shaped polyhydroxyalkanoate (PHA) scaffolds
seeded with vascular cells extracted from an ovine carotid artery. Histology showed a
significant increase in cell proliferation and there was extracellular matrix (ECM)
deposition in the fluid induced samples when compared to the static (no flow) samples.
Moreover, cells were aligned in the direction of the flow. Additionally, there was
presence of collagen and glycosaminoglycans (GAGs). However, there was no evidence
of elastin production. It was not clear if the increase in tissue formation was caused by
the increase number of cells or the pulsatility of the fluid. Evidence regarding phenotype
changes was not reported.
Hoerstrup et al.[46] used a pulse duplicator bioreactor on tri-leaflet shaped
scaffolds made of polyglycolic acid (PGA) and an outer coat of poly-4-hydroxybutyrate
(P4HB). The constructs were seeded initially with ovine myofibroblasts with subsequent
seeding of endothelial cells (ECs). Subsequently, the construct was implanted in lambs.
Blood regurgitation due to inappropriate joining of the leaflets was observed soon after
in-vivo grafting.
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Zeltinger et al. [47] used a bioreactor composed of a pneumatic pump used for
inducing flow on a decellularized aortic valve from a porcine. Neonatal fibroblasts from
humans were added to the flowing media and it continued to recirculate for 24 hours. The
study demonstrated that decellularized scaffolds could be populated by colonizing cells.
However, the construct failed due to valve stenosis, specifically by thickening of the
cusps soon after implantation.
Sutherland et al. [29] developed a TEHV seeded with carotid artery-derived
vascular smooth muscle cells (SMCs) and endothelial cells (ECs). The construct was
implanted in sheep for up to 20 weeks. Cell differentiation towards a heart valve
phenotype was observed after post-surgical examination.
Stickler, et al. [39] developed a device capable of cyclic stretch and implanted it
on the peritoneal cavities in eight sheep. The implant was designed such that cells
migrate to the scaffold. The results compared tissue samples cultured under static
conditions versus cyclic stretching. It was determined that there was significantly more
tissue formation in samples exposed to cyclic stretching, specifically that the mechanical
properties of the tissue were enhanced by a factor of two.
Lichtenberg et al. [48] used a simple pulsatile bioreactor in order to
mechanically stimulate a decellularized ovine pulmonary valve seeded with ECs. After
ECs colonization of the scaffold, a continuous layered architecture was seen. Next, the
graft was implanted in an ovine, and it performed satisfactorily at the initial stage.
However, subsequent studies revealed onset of thrombosis and hyperplasia.
Ceborati et al. [49] collaborated with the Haverich’s group [48] and conditioned
two decellularized human pulmonary valves seeded with endothelial progenitor cells
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(EPCs). The grafts were implanted in two pediatric patients. Presently, the two patients
have been observed to be in good health. Furthermore, the annulus of the graft has shown
to have grown with the patient.
Despite the promising results mentioned above, there remain many uncertainties
when looking at the future of TEHVs. It is well known that stem cells respond to
chemical and mechanical cues, and that they phenotypic transformation can be guided.
Mechanical stimulation has also shown to regulate the process of tissue formation. What
it is not clear yet, is what specific flow physics is causing cells to produce more matrix
and to differentiate viable progenitor cell types towards the heart valve lineage.
Custom bioreactors for HVTE studies are laboratory tissue-culture devices that
can provide a controllable, mechanically active environment that can be used to study and
potentially improve engineered tissue structure, properties, and integration. In some of
these devices the individual or combined effects of flow, stretch, and flexure (FSF)
stresses can be replicated and studied [38] In 2003, Engelmayr et al.[50] constructed a
bioreactor designed to provide engineered tissue constructs with flexural stress
conditioning. The biopolymeric scaffold was seeded with smooth muscle cells (SMCs).
The results showed that there was a decrease in the flexural strength of the acellular
scaffolds with increasing bending cycles. However, when the scaffold was seeded with
SMCs, the flexural stresses augmented engineered tissue formation.
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Figure 4. Custom made mechanical conditioning bioreactor for HVTE studies [38].
Modes: Flow, stretch, flexure.
Hildebrand et al.[51] developed a sophisticated bioreactor with a monitoring
system capable of introducing controlled pressure and waveforms independently. It used
a predictive control algorithm that could automatically modulate stroke volume, pump
rate, systolic and diastolic pressures. The device could incorporate a wide range of
pulsatile waveforms. Thus, it was able to condition grafts with physiologic and nonphysiologic flow conditions.
More recently, HVTE studies have used bone marrow derived mesenchymal stem
cells (BMSCs). BMSCs are a practical source autologous progenitor cells because they
can be obtained in large numbers in a minimally invasive manner [7,45,52,53].
Engelmayr, et al. [45] showed after 3 weeks of culture that, there was a significantly
higher amount of engineered tissue formation derived from BSMC-seeded scaffolds
under combined steady flow and flexure states, in comparison to steady flow or flexure
alone and to static controls. This finding suggested that cyclic flexure creates specific
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flow environments in steady flow states that caused the cells to produce more ECM.
Studies elsewhere have also provided evidence of flow vortices on the leaflets of native
valves (aortic side) that seem to provide the physiological benefit of more complete valve
closure[54,55]. More recently these vortices can be recapitulated in rectangular scaffolds
that have a bent configuration [7,45] and have been shown to be analogous to vortices
observed in tri-leaflet heart valves.
Ramaswamy et al. [7,45] had previously proposed the hypothesis that oscillatory
shear stress (OSS) caused by time-varying flow environments, triggered by bending
geometries, play a critical role in engineered tissue formation derived from BMSCs.
There is strong evidence to support this hypothesis in other tissue engineering
applications such as bone. Specifically, OSS has been shown to influence BMSCs
proliferation and upregulate transcription factors responsible for phenotypic regulation
[52,56-59]. In particular, Li et al. [53] reported that OSS caused triggering of intracellular
calcium mobilization in BMSCs and regulation of osteogenic gene expression. These
findings translate to HVTE studies using BMSCs and may potentially augment
engineered tissue formation rates and supporting the heart valve phenotype.
It was noted that from observing native heart valve dynamics that from a
biomimetic standpoint, OSS can be created by means of pulsatility or by cyclic specimen
geometry changes. However, quantification of the individual or combined effects of these
variables to maximize OSS environments in vitro is to date, not known. Accordingly, this
study, examined and quantified the role that i) physiologically relevant scales of
pulsatility and ii) changes in geometry as a function of specimen flexure, have in creating
OSS conditions for dynamic culture of tissues. This work will allow for the study of
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valve like configurations and flow environments and the subsequent comparison of the
surrounding 3-D flow physics under steady and pulsatile conditions. This will permit the
identification of specific fluid environments that may play a role in engineered heart
valve tissue formation.
4 METHODS
4.1 Methodology for aim 1 and 2
4.1.1 Initial Geometry and meshing for all simulations/fluid properties
Previous efforts have focused on the development of a u-shaped bioreactor capable
of inducing flow, flexure and tension on rectangular scaffolds (Fig. 5A) [8]. The fluid
domain of the u-shape bioreactor was constructed (Fig. 1D) through Ansys™
commercial software (Ansys Inc, Canonsburg, PA). The mesh was constructed with
tetrahedral elements (Fig. 6A) Physical properties for bioreactor media were used with
density = 1.01 g cm3 and dynamic Viscosity = 1.27 centipoise. Simulations were run in
a Hewlett Packard™ work station with intel(R) Xeon(R) CPU, x5550@ 2.67GHz
(2processors) with 16.0 GB installed memory and 64-bit windows 7 operating system.
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Figure 5. (A) Peristaltic pump used to induce flow through the FSF bioreactor.
(B) FSF bioreactor set up. (C) Single FSF bioreactor chamber. (D) Bioreactor
fluid domain showing the position of the three rectangular specimens.

Figure 6. (A) Tetrahedral mesh with 3.1x106 elements and 5.5x105 nodes. (B)
Close up of the mesh near the sample region. (C) Sample showing inner and outer
wall and the specimen straight, semi-bent, and fully-bent geometries.
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4.1.2 Displacement and Non-linear constant calculations
In the u-shaped bioreactor, the three rectangular- shaped specimens was fixed on
one end and permitted to move linearly with the use of an actuator (UltraMotion,
Cutchogue, NY) from the other end. The actuator moved 0.5 inches forward in 0.5
seconds and 0.5 inches back to the initial position in the next 0.5 seconds. Therefore,
the duration of one full cycle is one second (frequency of 1Hz). A fortran code was
written using the equations that govern the actuator displacement, and 250 displacement
values were obtained at an interval of 2 milliseconds. These values represented the axial
displacement of the actuator for half a cycle (0.5 seconds). Specimens were assumed to
take a parabolic shape and fit to the arc equation, given by:
.

1
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Eq.1

Where b is the new position of the moving end as it moved to the stationary end
and C is the nonlinear parabolic constant. The shape conformed to the equation of an
arc with the constraint of a fixed specimen axial length of 17 mm. In this way, the
sample length was preserved at each axial displacement and the nonlinear constant is
obtained. The constant, “C” was computed numerically in Mathcad™ (v.15, PTC,
Needham, MA) over a total of 250 time steps.
4.1.3 Tests for Independence
Independence tests were performed on meshing, time step, and periodicity for
steady and pulsatile simulations accordingly. As the monitored variable, the area
averaged wall shear stress on the samples was used. A 5% error acceptance criterion in
comparison with highly resolved simulations was employed.
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4.1.4 Methodology for aim 1- Steady state simulations
From the 250 spatial positions, efforts focused on building an initial mesh at t =
0 (fully straight state) and 10 subsequent meshes equally spaced, such that the last mesh
corresponded to the fully flexed state (t = 0.5 s). The time step between these meshes
was 50 ms. In this manner a quasi-static analysis of the flow field across these 11 static
meshes was conducted. The boundary condition at the inlet was specified to be a plug
velocity of 2.2 cm/s. Also, the outlet was set to an opening static pressure of 0 Pa.
4.1.5 Methodology for aim 2- Static pulsatile simulations
For the pulsatile simulations, a pulmonary artery flow rate waveform obtained
from Lotz et. al. [60] was used. The waveform had a total duration of 1.2 seconds for
one full cycle, and it was adjusted such that it has duration of one second. This was
done because previous calculations for the axial displacements and non-linear constants
used a 1-second cycle (Fig. 7a). Subsequently, the waveform was conversed to time
(seconds) vs velocity (cm/s) (Fig. 7b) and used as the inlet velocity profile.

(A)
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(B)
Figure 7. A) Flow rate waveform adjusted from 1.2 sec (original from lotz, et. at.[60]
) to 1 sec. B) Velocity waveform with a velocity average of 0.199386 cm/s.
Steady

Pulsatile

Flow

Laminar Flow

Laminar Flow

Walls

Walls-No slip conditions

Walls-No slip conditions

Inlet

Plug velocity
0.02 m/s

Velocity waveform

Outlet

Outlet-Opening pressure
= 0 Pa

Outlet-Opening pressure
= 0 Pa

Convergence

5x10-5

5x10-5

Table 1. Parameters for steady and pulsatile simulations.
4.1.6 Oscillatory Shear Stress
Oscillatory shear stresses were quantified by means of an oscillatory shear index (OSI),
as described by He and Ku[61] . OSI can be obtained by using the following equations.
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T

1
OSI = ( )(1 − T
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 τdt
0

)

Eq.5

 abs(τ )dt
0
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T

τdt

= The magnitude of the time averaged shear stress

Eq.6
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T

In the quasi static analysis  τdt can be obtained by using the following equation:
0
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) + ( i =0

11

i
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Eq.7

can be obtained as follows:

11

 (SSxi + SSyi + SSz i )

2

i =0

Eq.8

11
Where
SSxi = x component of shear stress

Eq.9

SSy i = y component of shear stress

Eq.10

SSz i = z component of shear stress

Eq.11

i = 1,2,3…11 represents the number of each of the eleven sample geometries where 1

represents the number of each of the eleven sample geometries.
i = 1,2,3…11 represents the number of each of the eleven sample geometries where 1

represents the straight geometry and 11 represents the fully bent position.
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T

T

0

0

For the pulsatile case  τdt and

 abs(τ )dt

can be obtained by using equation Eq. 7 and

Eq.8. In this case,
i = 1,2,3…11 represents 11 waveform time points evenly spaced, where 1 represents time

at t = 0 and 11 represents time at t = 1 second.
4.2 Methodology for aim 3- Cell Culture experiments
4.2.1 Cell Differentiation: BMSCs were cultured in T-75 flasks in a 37oC incubator until

100% confluence was reached. The cells were split to obtain a cell density of 17x106
cells/cm2 and cultured for an additional week. Group 1(n=4) contained BMSC cultured in
a 96 well-plate under static flow. Group 2 (n=4) this group of BMSCs was cultured in the
Bioflux 200 system (Fluxion Biosciences, San Francisco, CA) and exposed to steady
flow with a shear stress of 1.5dyn/cm2. Group 3 (n=4) - contained BMSCs cultured in the
Bioflux 200 system and exposed to a pulsatile shear stress obtained from a physiological
pulmonary valve waveform [60].
4.2.2 Culture Media: The media contained DMEM High glucose (Invitrogen, Carlsbald,

CA), 10% fetal bovine serum (ATCC, Manasas, VA), 1% antibiotic/antimycotic, 1%
HEPES (Invitrogen, Carlsbald, CA), 2ηg/mL of basic fibroblast growth factor (bFGF,
Invitrogen, Carlsbald, CA), 82µg/mL Ascorbic Acid (Sigma-Aldrich, St. Louis, MO).
The media was changed every 24 hours for a period of one week. The amount of media
added to each well for the 24-microfluidic well plate, was 3ml, and for the 96-well plate
(group 1) was 200µL. The 82µg/mL of Ascorbic acid was added to the media.
4.2.3 Bioflux 200 System: The Bioflux 200 system consists of a pneumatic pump, a 24-

microfluidic well plate, a 24-well plate interface, and a user operated software. The
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system allows inputting the desired shear stress for both continuous and pulsatile flow.
The Bioflux 200 is connected to a microscope with a CCD camera allowing the user to
take photographs of the cultured cells under flow. This system is efficient for stem cell
applications, such as cell differentiation.
4.2.4 Assays:

Cell Differentiation-RNA Isolation and Reverse Transcription: SMCs were washed with
PBS and removed from the T-75cm2 flask (Fisher Scientific, PA) by 0.25%TrypsinEDTA (ATCC, Manasas, VA). Then, the detached cells were gathered in a 15 ml conical
tube (Fisher Scientific, PA). In order to perform the RNA isolation procedure, the cells
were transferred to a 1.5 ml RNAase free tube. Total mRNA was purification of mRNA
was performed through the SV Total RNA Isolation System (Promega, Madison, WI).
Reverse transcription reaction was performed on 1µg of total mRNA with GoScript™
Reverse Transcription System (Promega, Madison, WI). Detection was performed by
using a Step One Real-Time PCR System (Applied Biosystems, Carlsbad, CA). The
cycling parameters were 950C, 5 seconds; 600C, 45 seconds; 950C, 15 seconds.
4.2.5 Statistics

Independent two sample t-test
_

t=

_

x1 − x 2

Eq.12

2
(S X1 X 2 )
n

Where
S X1 X 2 =

1 2
( S X1 + S X2 1 )
2

Eq.13
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S X2 1 = variance of first group
S X2 2 = variance of second group
Degrees of freedom = 2n-2
n = number of samples
Assumptions:
Equal variance
5 RESULTS FOR AIM 1 AND AIM 2

CFD simulations were run with the U-shaped tube geometry, housing three
rectangular specimens that depicted a conditioning chamber of the bioreactor. Solution
convergence was achieved at the prescribed residual values for continuity and motion
equations (<5.0 x 10-5). Uniformity in shear stresses between specimens (N =3
specimens) housed within the bioreactor was observed and was found to be consistent
with previous studies [8] inter-specimen variation of shear stresses was all found to be
within 5% in all simulations performed.
As shown in Figure 8, there is higher variability of shear stress magnitude in the
outer wall of the samples for both pulsatile and quasi-static scenarios. The outer walls
show higher shear stress at the upstream region when compared to the downstream area.
Average inner wall specimen shear stresses (N=3) were found to be 0.05 Pa (straight),
0.09 Pa (semi-bent) and 0.1 Pa (fully-bent), whereas the time-averaged shear stress over
11 specimen configurations was found to be 0.03 Pa (quasi-static) (Fig. 9). Average outer
wall shear stresses were 0.05 Pa (straight-pulsatile), 0.12 Pa (semi-bent-pulsatile), 0.17
Pa (fully-bent-pulsatile), and a time-average shear stress of 0.11 Pa was computed from
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the quasi-static analysis (Fig. 9). In brief, the outer wall shear stress is higher when
compared to the inner wall. This is due to higher momentum forces acting on the outer
surface due to the moving flow that encounters it.

Figure 8. Time averaged wall shear stress distributions in the inner (n=3)
and outer (n=3) walls of the specimen for three geometry positions under pulsatile
and quasi-static conditions.
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Figure 9. Bar chart showing time averaged shear stress.

The direction of the shear stress vectors at different instantaneous velocities in
one full cycle was observed (Fig 10-16). Particularly, observations were performed at
the higher velocity range in the waveform because there are more fluid environments
alterations in this area. Specifically, three time intervals during the acceleration phase (t
= 0.028 sec, vel= 2.9 cm/s; t = 0.05 sec, 2.9 cm/s; t = 0.1, sec 5.2 cm/s) were observed,
maximum velocity (t = 0.13, sec 8.9cm/s), and three time intervals during the
deceleration phase (t = 0.168 sec, 7.6 cm/s; t = 0.256 sec, 5.2 cm/s; t = 0.314, sec 2.9
cm/s). It was observed that in the straight samples (Fig 6, 7) shear stress vectors travel in
the same direction as the flow during the acceleration period. On the other hand, these
vectors were found to be in the complete opposite direction to the flow during the
deceleration phase. For the case of the semi-bent and fully bent cases, it was observed
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that the wall shear vectors change direction even at the acceleration phase. This is
particularly visible at the inner walls.

Figure 10. Inner wall of a straight sample shear stress magnitude with
superimposed wall shear vectors.
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Figure 11. outer wall of a straight sample shear stress magnitude with superimposed
wall shear vectors.

Figure 12. Inner wall of a semibent sample shear stress magnitude with
superimposed wall shear vectors.
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Figure 13. Outer wall of a semibent sample shear stress magnitude with
superimposed wall shear vectors.

Figure 14. Inner wall of a fully-bent sample shear stress magnitude with
superimposed wall shear vectors.
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Figure 15. Outer wall of a fullybent sample shear stress magnitude with
superimposed wall shear vectors.
In order to observe the role that velocity acceleration and deceleration had on the

direction of shear stress streamlines, an instantaneous velocity of 2.2 cm/s for both
phases of acceleration was used. This is also the velocity that was used as the inlet
condition for the steady state simulations. Specimen friction streamlines were found to
be in the fully forward direction under steady flow and during the acceleration phase of
the pulsatile flow waveform (Fig. 16). On the other hand, complete flow reversal was
observed during the deceleration phase on both the inner and outer walls of the
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specimens.

Figure 16. Shear stress streamlines on the outer and inner walls of a straight
sample under steady (vel=0.022m/s) and pulsatile conditions.

Observations on the axial shear stress profiles for three sample configurations
simulated under steady profiles was done (Fig. 17). Shear stress vectors show the
direction of the flow when the sample was in a straight configuration. Shear stress
vectors did not follow the direction of the flow when the sample was semi or fully-bent.
This observation can be seen more clearly in the inner walls of the samples.
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Figure 17. Axial shear stress (Flow direction) streamlines on the outer and inner
walls of a straight sample in steady state cases (vel=2.2cm/s).

Figures 18 and 19 show the axial shear stress at different instantaneous
waveform velocities with straight sample positions. The vectors follow the direction of
the flow in the inner wall. There was a slight change in the direction of the vectors at the
last instantaneous velocity of the deceleration phase in the outer wall (Fig 19). Axial
shear stress magnitude increased with increasing velocity (Fig 20, 21).
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Figure 18. Inner wall of a straight sample with superimposed axial (Flow-direction)
shear stress vectors at steady and instantaneous velocities.

Figure 19. Outer wall of a straight sample with superimposed axial (Flow-direction)
shear stress vectors at steady and instantaneous velocities.
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Figure 20. Inner wall of a straight sample showing axial shear stress magnitude at
steady and instantaneous velocities.

Figure 21. Outer wall of a straight sample showing axial shear stress magnitude at
steady and instantaneous velocities.
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OSI variability was highest along the inner and outer walls (N=3 specimens) in
the quasi static case (Fig.22). On the other hand, OSI variability was lowest along the
inner and outer walls of straight samples (N=3) subjected to pulsatile flow. OSI
distribution was highest along both the inner and outer walls when specimens (N=3) were
held fixed in a straight configuration (average specimen OSI = 0.26, inner wall; average
specimen OSI = 0.27, outer wall) and subjected to a physiologically-relevant pulsatile
flow field (Fig.23). From the quasi-static analysis, when the flow was steady, the OSI
reduced by ~ 62% on the inner wall and ~ 8% on the outer wall. Finally, when the
specimen configuration was fixed in a bent-state, the OSI decreased in comparison to the
straight specimens under pulsatile flow conditions (Fig.23). In addition, OSI was plotted
along the centerline of one sample (Fig. 24 & 25).

Figure 22. Oscillatory shear index contour for the inner (n=3) and outer walls (n=3).
It shows four cases: straight pulsatile, semi-bent pulsatile, fully-bent pulsatile
and quasi-static.
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Figure 23. Bar chart showing OSI.

Figure 24. Inner wall OSI distribution along the centerline of samples.
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Figure 25. Outer wall OSI distribution along the centerline of samples.
Observations for velocity in the steady cases were conducted by using a centerline
through the upper chamber of the bioreactor as shown on figure 26a. Initial observations
on the lower chamber did not show significant velocity changes. Regions of velocity
absence was observed for the semi-bent and fully bent geometries. This was due to higher
sample flexures that intersected and surpassed the centerline of the chamber (Fig. 26b).
Interestingly, the velocity increased as it approached the sample location and it further
augmented as it encountered the second and third sample. The velocity closer to the
outlet was higher that the velocity at the start of the chamber. This suggests that the
presence of the sample created a narrowing in the total cross sectional area of the
chamber and it resulted in observed velocity intensification.
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(a)

(b)

Figure 26. (a) Centerline showing the upper and lower chamber of the u-shaped
bioreactor (b) Steady state velocity at the upper chamber centerline for three
sample configurations.

In order to have a better understanding of the velocity profile found in straight
samples subjected to pulsatility, the velocity at the center line of the upper chamber (Fig.
26a) at specific time intervals was plotted. Specifically, these observations were done at
0.1 sec (Fig. 27), 0.13 sec (Fig. 28), 0.15 sec (Fig. 29), and 0.2 sec (Fig. 30). The time t
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= 0.13 sec, corresponds to the highest velocity value (8.9cm/s) from the waveform and
shows higher velocity magnitudes over the other time points (Fig. 28). Interestingly, the
velocity at the x = 0 m (beginning of the chamber) are remarkably similar to the velocity
close to the outlet. In addition, there is an increase in velocity in the proximity of the
samples, but it decreases as it passes away from them. Furthermore, these velocity
increments are remarkably similar among the centerline regions in proximity with the
samples.

Figure 27. Velocity along the centerline at t = 0.1 sec (straight samples).

Figure 28. Velocity along the centerline at t = 0.13 sec (straight samples).
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Figure 29. Velocity along the centerline at t = 0.15 sec (straight samples).

Figure 30. Velocity along the centerline at t = 0.2 sec (straight samples).

Time averaged vorticity magnitudes along the centerline of the upper chamber
were plotted (Fig. 31). Regions of vorticity absence was observed for the semi-bent and
fully bent geometries. This was due to higher sample flexures that intersected and
surpassed the centerline of the chamber. Similarly, this may have played a role in the
quasi-static vorticity quantification due to highly flex samples. Figure 31 reveals areas of
very high vorticity magnitude in regions of close proximity to the upstream side of the
samples. In the case of the straight configuration, vorticity centerline profiles showed
remarkable similarity among samples. Because of this it was decided that a closer look at
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the centerline vorticity of straight samples needed to be performed. The instantaneous
vorticity at t = 0.13 sec corresponding to the highest velocity point (8.9cm/s) was
designed (Fig. 32).

Time Averaged Vorticity (Upper Chamber)
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Figure 31. Time average vorticity along the centerline of the upper chamber for
pulsatile and quasi-static.

Figure 32. Instantaneous vorticity along the centerline of the upper chamber with
straight samples and pulsatile flow.
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5.1 Discussion

In cardiovascular tissue engineering, there is widespread agreement that dynamic
culture using mechanical conditioning protocols, promotes tissue formation. It is been
shown that in-vitro conditioning by means of flow environments enhances engineered
tissue formation [1,7,8] and regulate specific transcription factors of progenitor cells that
modulate phenotype [16,54]. However, the explicit flow criteria for supporting tissue
growth, in the context of HVTE efforts have not been sufficiently identified. Thus, there
is ambiguity on the precise fluid-induced mechanisms governing the production of de
novo valve tissue [7,8,45]. Some observations suggest that it is the oscillatory stress
environments that are responsible for stimulating tissue development [7,38].
This study investigated and quantified the role that i) specimen configuration and
ii) use of a physiologically relevant pulsatile flow waveform have on creating OSS
environments. It was found that

physiologic OSS environments are maximized when

specimens were placed in a fixed, straight configuration and were exposed to a pulsatile
waveform [60]. Moreover, this setting comes accompanied with a highly uniform OSS
distribution across all samples housed within the bioreactor thereby ensuring minimal
variation in engineered tissue formation between specimens.
These findings demonstrate that OSS focused experiments for HVTE does not
require a moving component and simplifies the design of a bioreactor for supporting
these investigations. However the flow source has to be able to incorporate physiological
waveforms and induce pulsatile flow through the conditioning chamber. This can be
readily accomplished using a peristaltic pump [8]. [38] reported higher tissue formation
under conditions of flow and flexure combined. The quasi-static results suggest that this
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could be partially due to the OSS environments caused by cyclic alteration in the fluid
environments due to the deforming sample submerged into the continuous flow.
Engelmayer et al. (2006) [16] reported an increase in number of cells and tissue
formation in constructs conditioned by means of pulsatile flow over controls (no flow).
The pulsatile simulations over static scaffolds subjected to pulsatile flow regimes
suggest that OSS might have played a role in these findings by promoting cell
proliferation and tissue formation. Support for this belief can be found in bone tissue
engineering studies [53,62]. It should be noted that a limitation of this study was that it
did not account for fully dynamic states; rather it took a quasi-static approach in
considering OSS environments resulting from changing specimen configurations. A true
dynamic CFD simulation would require incorporation of fluid-structure or other moving
boundary approaches which would require more computational implementation and time,
yet unnecessary for the purposes of a primary objective here, which was to reasonably
approximate the OSS distributions on the specimens. This was achieved by the quasistatic model, firstly by the use of meshes that accurately depicted varying specimen
geometry at snapshot temporal positions. Secondly, the model operated in the laminar
range and was prescribed a uniform inlet velocity condition, which would enable any
given fluid particle in the conditioning chamber to come into regular, periodic contact
with a housed specimen undergoing cyclical flexure, thus having roughly the same shape
at that time instant.
Another limitation is that it only considered the singular effect of OSS on tissue
formation which is thought to be beneficial [7,8,63]. It is however important to note that
specimen movement may provide added benefits to tissue formation, by enhancing mass
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transport of nutrients to the growing tissues. Efforts are currently investigating the role
of valve-like specimen movement on engineered tissue formation by BMSCs in
bioreactor-based experiments that are being conducted in our laboratory. In summary,
this report has shown that OSS can be maximized by inducing pulsatile flow over straight
scaffolds. There is strong evidence to believe that OSS promotes BMSCs tissue
formation.
6 RESULTS AND DISCUSSION FOR AIM 3

HVTE studies have shown that pulsatile environments can promote cell
proliferation and tissue formation. This study has shown, through CFD analysis, that
during pulsatility there are high areas of OSS acting on the surface of rectangular
specimens. In addition, these environments can be maximized by conforming to a straight
sample configuration. As a next step, efforts to performed in-vitro studies of BMSCs
cultured under no flow and steady flow regimens are underway.
Initially, ΔCt values were averaged and were subsequently normalized with GAPDH.
Statistical t-tests were performed over the 2-ΔCt values for comparison among no flow
and steady flow groups. The results showed an increase in the number of cells attached to
the walls of the micro channel with increasing culture time (Fig. 33). The effect of flow
compared to no flow on BMSCs was significantly different (P < 0.05). Specifically,
significant differences were observed on B-1-INT, PECAM-1, and VECADHERIN (Fig.
34). B-1-INT is associated with extracellular matrix formation (i.e Collagen) [1].
PECAM-1 is an adhesion molecule expressed by vascular ECs [46]. VECADHERIN is
important in supporting the EC phenotype and has a critical role in vascular development
[58].
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Pulsatile in-vitro experiments are currently in progress and will provide with quantitative
data to assertively delineate any cell proliferation and phenotypic differences between
steady and pulsatile flow conditions. In addition, in subsequent in-vitro experiments,
evaluation of tissue formation will be performed. Nonetheless, it can be concluded that
steady flow alone promotes cell proliferation and phenotypic differentiation.
The quasi-static results showed that OSS environments can be caused by means of
cyclic sample flexure. Previous in-vitro experimental data obtained from samples
cultured under cyclic flexure combined with flow conditions show higher tissue
formation over controls of flow or cyclic flexure alone (Fig. 35). In addition, flex and
flow combined groups showed higher elastic modulus than the other groups.

Figure 35. Collagen assay results for BMSC-seeded 50:50 PGA/PLLA scaffolds [38].
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Similarly, Ramaswamy et al. [7] reported increase in tissue formation in scaffolds
seeded with BMSCs and conditioned by means of dynamic sample movement. They used
a native valve-like (organ level) geometries and rectangular scaffolds (FSF-level). The
organ level constructs subjected to dynamic conditioning had highest collagen production
followed by the dynamic regimen of rectangular samples (Fig. 35).

Figure 36. A compilation of the temporal evolution of collagen mass production for
all groups investigated at the tissue and organ levels [7].
7 CONCLUSION

Through a computational modeling approach this study has shown that OSS can
be maximized by inducing pulsatile flow over straight scaffolds. Specifically, these
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results have shown that in average OSS environments show higher magnitude and that
there it is more homogeneously distributed along the sample walls. These findings
demonstrate that experiments for HVTE that focus on OSS do not require a moving
component. In this way, bioreactor designs could be further simplified to accommodate
for pulsatility rather than movement by means of external actuators. It is our belief that
OSS promotes BMSCs proliferation and tissue formation. The results of this study have
shown that there is strong evidence to support this hypothesis. Current efforts are focused
on in-vitro experiments that will provide with quantifiable data.
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